DPT Laboratories and Confab, a DPT company specializing in complex solids, semi-solids and liquids, have completed a $10 million investment at its sites in San Antonio and Montreal.
 
DPT has invested in a new compounding suite and upgrades to production filling lines in San Antonio that will increase capacity, throughput and precision. Additional upgrades include enhanced security to further restrict access to the manufacturing floor and enhance GMP compliance.
 
Confab expanded its R&D capabilities with a new laboratory, new equipment, and additional R&D personnel. Confab can now offer pharmaceutical development capabilities ranging from formulation development and analytical method development to technology transfers at commercial scale.
 
“The investments in capital demonstrate our continuing commitment to provide high-quality development and manufacturing solutions to our partners,” said Paul Josephs, senior vice president of sales, marketing and corporate development. “We are excited about the strong demand for our services and look forward to discussing our enhanced capabilities with our customers during DCAT week.”